Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ryan Corces

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Neuron|July 29, 2025
Human brain vascular multi-omics elucidates disease-risk associationsMadigan M Reid, Shreya Menon, Hao Liu, et al.
Cell Stem Cell|January 17, 2017
Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of DiseaseMark P Chao, Andrew J Gentles, Susmita Chatterjee, et al.
Cell Reports|September 28, 2017
Rapid Chromatin Switch in the Direct Reprogramming of Fibroblasts to NeuronsOrly L Wapinski, Qian Yi Lee, Albert C Chen, et al.
Neuron|January 30, 2022
Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibilityMandy Meijer, Eneritz Agirre, Mukund Kabbe, et al.
Parkinsonism & Related Disorders|October 1, 2025
Epigenomic profile of GBA1 in Parkinson's diseaseEloise Berson, Raphael Zaghroun, Matteo Santoro, et al.
Cancer Discovery|July 22, 2017
Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα AgonistMichael R McKeown, M Ryan Corces, Matthew L Eaton, et al.
Journal of Neuroinflammation|December 13, 2025
Human iPSC-derived APOE4/4 Alzheimer´s disease astrocytes exhibit a senescent and pro-inflammatory state that compromises neuronal supportLaura Caceres-Palomo, Elisabeth Sanchez-Mejias, Laura Trujillo-Estrada, et al.
Nature Genetics|October 27, 2020
Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer's and Parkinson's diseasesM Ryan Corces, Anna Shcherbina, Soumya Kundu, et al.
Nature Communications|August 16, 2023
Whole genome deconvolution unveils Alzheimer's resilient epigenetic signatureEloise Berson, Anjali Sreenivas, Thanaphong Phongpreecha, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2025
<i>APOE</i> *4 Risk-Modifying Genes and Drug Targets in Alzheimer's Disease through Cell-Type Specific Genomic AnalysesYoujie Zeng, Noah Cook, Chenyu Yang, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Neuron|July 29, 2025
Human brain vascular multi-omics elucidates disease-risk associationsMadigan M Reid, Shreya Menon, Hao Liu, et al.
Cell Stem Cell|January 17, 2017
Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of DiseaseMark P Chao, Andrew J Gentles, Susmita Chatterjee, et al.
Cell Reports|September 28, 2017
Rapid Chromatin Switch in the Direct Reprogramming of Fibroblasts to NeuronsOrly L Wapinski, Qian Yi Lee, Albert C Chen, et al.
Neuron|January 30, 2022
Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibilityMandy Meijer, Eneritz Agirre, Mukund Kabbe, et al.
Parkinsonism & Related Disorders|October 1, 2025
Epigenomic profile of GBA1 in Parkinson's diseaseEloise Berson, Raphael Zaghroun, Matteo Santoro, et al.
Cancer Discovery|July 22, 2017
Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα AgonistMichael R McKeown, M Ryan Corces, Matthew L Eaton, et al.
Journal of Neuroinflammation|December 13, 2025
Human iPSC-derived APOE4/4 Alzheimer´s disease astrocytes exhibit a senescent and pro-inflammatory state that compromises neuronal supportLaura Caceres-Palomo, Elisabeth Sanchez-Mejias, Laura Trujillo-Estrada, et al.
Nature Genetics|October 27, 2020
Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer's and Parkinson's diseasesM Ryan Corces, Anna Shcherbina, Soumya Kundu, et al.
Nature Communications|August 16, 2023
Whole genome deconvolution unveils Alzheimer's resilient epigenetic signatureEloise Berson, Anjali Sreenivas, Thanaphong Phongpreecha, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2025
<i>APOE</i> *4 Risk-Modifying Genes and Drug Targets in Alzheimer's Disease through Cell-Type Specific Genomic AnalysesYoujie Zeng, Noah Cook, Chenyu Yang, et al.
Pageof 7